Related Experiment Video
Updated: May 15, 2026

Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos
Published on: April 14, 2023
RhoJ modulates melanoma invasion by altering actin cytoskeletal dynamics
Hsiang Ho1, Amelia Soto Hopkin, Rubina Kapadia
1Department of Medicine, University of California, Irvine, Irvine, CA, USA.
Abstract:
Rho family GTPases regulate diverse processes in human melanoma ranging from tumor formation to metastasis and chemoresistance. In this study, a combination of in vitro and in vivo approaches was utilized to determine whether RHOJ, a CDC42 homologue that regulates melanoma chemoresistance, also controls melanoma migration. Depletion or overexpression of RHOJ altered cellular morphology, implicating a role for RHOJ in modulating actin cytoskeletal dynamics. RHOJ depletion inhibited melanoma cell migration and invasion in vitro and melanoma tumor growth and lymphatic spread in mice. Molecular studies revealed that RHOJ alters actin cytoskeletal dynamics by inducing the phosphorylation of LIMK, cofilin, and p41-ARC (ARP2/3 complex subunit) in a PAK1-dependent manner in vitro and in tumor xenografts. Taken together, these observations identify RHOJ as a melanoma linchpin determinant that regulates both actin cytoskeletal dynamics and chemoresistance by activating PAK1.
Insights
This study reveals RhoJ protein is crucial for melanoma cell migration and invasion. RhoJ activation of PAK1 influences actin dynamics, impacting tumor growth and spread.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Rho family GTPases are key regulators of melanoma progression, including metastasis and chemoresistance.
- RHOJ, a homologue of CDC42, has been implicated in melanoma chemoresistance.
Purpose of the Study:
- To investigate the role of RHOJ in melanoma cell migration and invasion.
- To elucidate the molecular mechanisms by which RHOJ influences melanoma progression.
Main Methods:
- Utilized in vitro and in vivo approaches, including RHOJ depletion and overexpression.
- Assessed cellular morphology, migration, invasion, tumor growth, and lymphatic spread.
- Conducted molecular studies on actin cytoskeletal dynamics and signaling pathways (PAK1, LIMK, cofilin, p41-ARC).
Main Results:
- RHOJ modulation altered melanoma cell morphology and actin cytoskeletal dynamics.
- RHOJ depletion significantly inhibited melanoma cell migration, invasion, tumor growth, and lymphatic spread in vivo.
- RHOJ activated PAK1, leading to phosphorylation of LIMK, cofilin, and p41-ARC, thereby altering actin dynamics.
Conclusions:
- RHOJ is a critical regulator of melanoma cell migration and invasion.
- RHOJ controls actin cytoskeletal dynamics and chemoresistance through PAK1 activation.
- RHOJ represents a potential therapeutic target for inhibiting melanoma progression.
Related Concept Videos
Cell Polarization by Rho Proteins
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cytoskeletal Coordination in Cell Migration
Cancer Cell Migration through Invadopodia
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

